March 14, 2006
AMERIPATH ANNOUNCES THE CONTINUED EXPANSION OF ITS GASTROINTESTINAL
DIAGNOSTIC SERVICES IN THE ATLANTA, GEORGIA, REGION
FOR IMMEDIATE RELEASE
Palm Beach Gardens, FL, March 14, 2006 — AmeriPath,
Inc., the nation’s largest company focused on providing
anatomic pathology, cancer diagnostics, and related health
care information services, is pleased to announce the expansion
of its GI diagnostic services in the Atlanta, Georgia,
area.
Dr. Jerrold A. Clark, newly appointed Director of GI Diagnostics,
AmeriPath Georgia, will head the development of AmeriPath’s
GI specialty services in the Georgia region, starting with
the expansion of a new 6,700 square-foot, high-technology
facility in Marietta, Georgia. Dr. Clark commented: “We
firmly believe in bringing high-quality pathology services
to the local medical community. Pathology is a critical
element in ensuring that a patient receives appropriate
treatment in a timely manner. The personal interaction
between the pathologist and local gastroenterologist is
crucial to enhancing the communication needed to provide
quality patient care. We are not merely a provider of test
results; we are an integral part of the gastroenterologist’s
consultative team.”
Dr. Clark’s experience encompasses over 25 years
in anatomic pathology, with subspecialization in GI pathology
and digestive disease. A graduate of the School of Medicine,
Southern Illinois University, Springfield, Illinois, Dr.
Clark completed his anatomic and clinical pathology residency
and fellowship training at the Vanderbilt University Medical
Center, Nashville, Tennessee. His formal medical education
also included a six-year postgraduate program that featured
a flexible graduate year — with a rotation in gastroenterology — at
Blodgett Memorial Medical Center, Grand Rapids, Michigan.
In addition Dr. Clark has trained with world-renowned GI
pathologist Robert E. Petras, M.D., the current Director
of AmeriPath’s Institute of Gastrointestinal Pathology
and Digestive Disease and Terry L. Gramlich, M.D., Director
of Hepatopathology.
Dr. Clark has served with honor and great distinction
in numerous key appointments within the clinical and
academic service arenas, to include the following:
· Associate professor, Mercer University School of Medicine,
Macon, Georgia
· Laboratory Director, Taylor Regional Hospital, Hawkinsville,
Georgia
· Laboratory Director, Bleckley County Hospital, Cochran,
Georgia
· Laboratory Director, Taylor-Telfair County Hospital,
McRae, Georgia
· Laboratory Director, Ocmulgee Outreach Pathology Services,
Macon, Georgia
Bruce Walton, AmeriPath’s President of Anatomic
Pathology, Eastern Region, commented: “We are pleased
and honored that Dr. Clark has accepted the position of
Director of GI Diagnostics, AmeriPath Georgia. Our focus
continues to be on the placement of local, highly qualified
GI pathologists— reinforced by the resources of a
national company — in order to achieve and maintain
a truly unparalleled record of excellence in support of
the medical communities and the patients we serve.”
Dr. Clark’s expertise and dedication to excellence
reinforce the strength and commitment of our medical staff
and fortify AmeriPath’s vision of providing quality
GI pathology services to our referring physicians in their
medical communities. As a physician-driven organization,
we understand the needs of clinicians and the importance
of providing specialists in their local communities. This
is what differentiates AmeriPath from the competition.
AmeriPath Georgia’s cutting-edge GI Diagnostics
services — in direct support of its clinician clientele —will
focus on primary GI histology, consultations on difficult
cases, and esoteric testing. Major emphasis will be placed
on assisting referring physicians in the early diagnosis
and management of GI disease.
AmeriPath, Inc. is a leading national provider of cancer
diagnostics, genomics, and related information services.
The company’s extensive diagnostics infrastructure
includes AmeriPath’s Institute of Gastrointestinal
Pathology and Digestive Disease and its Center for Advanced
Diagnostics. CAD provides specialized diagnostic testing
and information services, to include fluorescence in
situ hybridization, flow cytometry, DNA analysis, polymerase
chain reaction, molecular genetics, cytogenetics, and
HPV typing.
Company Contact:
Jean Van Buren
AmeriPath, Inc.
(800) 330-6565
jvanburen@ameripath.com
